Safranal, an active ingredient of saffron, attenuates cognitive deficits in amyloid β-induced rat model of Alzheimer’s disease: underlying mechanisms

被引:0
|
作者
Tourandokht Baluchnejadmojarad
Seyed-Mahdi Mohamadi-Zarch
Mehrdad Roghani
机构
[1] Iran University of Medical Sciences,Department of Physiology, School of Medicine
[2] Shahed University,Neurophysiology Research Center
来源
Metabolic Brain Disease | 2019年 / 34卷
关键词
Alzheimer’s disease; Amyloid β; Safranal; Learning and memory; Oxidative stress; Inflammation;
D O I
暂无
中图分类号
学科分类号
摘要
Alzheimer’s disease (AD) is the most prevalent neurodegenerative amyloid disorder with progressive deterioration of cognitive and memory skills. Despite many efforts, no decisive therapy yet exists for AD. Safranal is the active constituent of saffron essential oil with antioxidant, anti-inflammatory, and anti-apoptotic properties. In this study, the possible beneficial effect of safranal on cognitive deficits was evaluated in a rat model of AD induced by intrahippocampal amyloid beta (Aβ1–40). Safranal was daily given p.o. (0.025, 0.1, and 0.2 ml/kg) post-surgery for 1 week and finally learning and memory were evaluated in addition to assessment of the involvement of oxidative stress, inflammation, and apoptosis. Findings showed that safranal treatment of amyloid β-microinjected rats dose-dependently improved cognition in Y-maze, novel-object discrimination, passive avoidance, and 8-arm radial arm maze tasks. Besides, safranal attenuated hippocampal level of malondialdehyde (MDA), reactive oxygen species (ROS), protein carbonyl, interleukin 1β (IL-1β), interleukin 6 (IL-6), tumor necrosis factor α (TNFα), nuclear factor-kappa B (NF-kB), apoptotic biomarkers including caspase 3 and DNA fragmentation, glial fibrillary acidic protein (GFAP), myeloperoxidase (MPO), and acetylcholinesterase (AChE) activity and improved superoxide dismutase (SOD) activity and mitochondrial membrane potential (MMP) with no significant effect on nitrite, catalase activity, and glutathione (GSH). Furthermore, safranal prevented CA1 neuronal loss due to amyloid β1–40. In summary, safranal treatment of intrahippocampal amyloid beta1–40-microinjected rats could prevent learning and memory decline via neuronal protection and at a molecular level through amelioration of apoptosis, oxidative stress, inflammation, cholinesterase activity, neutrophil infiltration, and also by preservation of mitochondrial integrity.
引用
收藏
页码:1747 / 1759
页数:12
相关论文
共 50 条
  • [21] Krill Oil Attenuates Cognitive Impairment by the Regulation of Oxidative Stress and Neuronal Apoptosis in an Amyloid β-Induced Alzheimer's Disease Mouse Model
    Kim, Ji Hyun
    Meng, Hui Wen
    He, Mei Tong
    Choi, Ji Myung
    Lee, Dongjun
    Cho, Eun Ju
    MOLECULES, 2020, 25 (17):
  • [22] Oridonin Attenuates Synaptic Loss and Cognitive Deficits in an Aβ1-42-Induced Mouse Model of Alzheimer's Disease
    Wang, Sulei
    Yu, Linjie
    Yang, Hui
    Li, Chaosheng
    Hui, Zhen
    Xu, Yun
    Zhu, Xiaolei
    PLOS ONE, 2016, 11 (03):
  • [23] Phloroglucinol Attenuates the Cognitive Deficits of the 5XFAD Mouse Model of Alzheimer's Disease
    Yang, Eun-Jeong
    Ahn, Sangzin
    Ryu, Junghwa
    Choi, Moon-Seok
    Choi, Shinkyu
    Chong, Young Hae
    Hyun, Jin-Won
    Chang, Moon-Jeong
    Kim, Hye-Sun
    PLOS ONE, 2015, 10 (08):
  • [24] A transgenic rat that develops Alzheimer's disease-like amyloid pathology, deficits in synaptic plasticity and cognitive impairment
    Liu, Li
    Orozco, Ian J.
    Planel, Emmanuel
    Wen, Yi
    Bretteville, Alexis
    Krishnamurthy, Pavan
    Wang, Lili
    Herman, Mathieu
    Figueroa, Helen
    Yu, W. Haung
    Arancio, Ottavio
    Duff, Karen
    NEUROBIOLOGY OF DISEASE, 2008, 31 (01) : 46 - 57
  • [25] Transplantation of GABAergic Interneuron Progenitor Attenuates Cognitive Deficits of Alzheimer's Disease Model Mice
    Lu, Mei-Hong
    Zhao, Xiu-Yun
    Xu, De-En
    Chen, Ji-Bo
    Ji, Wen-Li
    Huang, Ze-Ping
    Pan, Ting-Ting
    Xue, Lu-Lu
    Wang, Fen
    Li, Qi-Fa
    Zhang, Yue
    Wang, Ting-Hua
    Yanagawa, Yuchio
    Liu, Chun-Feng
    Xu, Ru-Xiang
    Xia, Yi-Yuan
    Li, Shao
    Ma, Quan-Hong
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 75 (01) : 245 - 260
  • [26] Avicularin Attenuates Memory Impairment in Rats with Amyloid Beta-Induced Alzheimer’s Disease
    Nikita Patil Samant
    Girdhari Lal Gupta
    Neurotoxicity Research, 2022, 40 : 140 - 153
  • [27] Avicularin Attenuates Memory Impairment in Rats with Amyloid Beta-Induced Alzheimer's Disease
    Samant, Nikita Patil
    Gupta, Girdhari Lal
    NEUROTOXICITY RESEARCH, 2022, 40 (01) : 140 - 153
  • [28] Oral administration of methysticin improves cognitive deficits in a mouse model of Alzheimer's disease
    Fragoulis, Athanassios
    Siegl, Stephanie
    Fendt, Markus
    Jansen, Sandra
    Soppa, Ulf
    Brandenburg, Lars-Ove
    Pufe, Thomas
    Weis, Joachim
    Wruck, Christoph Jan
    REDOX BIOLOGY, 2017, 12 : 843 - 853
  • [29] Trigonelline protects hippocampus against intracerebral Aβ(1–40) as a model of Alzheimer’s disease in the rat: insights into underlying mechanisms
    Javad Fahanik-Babaei
    Tourandokht Baluchnejadmojarad
    Farnaz Nikbakht
    Mehrdad Roghani
    Metabolic Brain Disease, 2019, 34 : 191 - 201
  • [30] Voglibose attenuates cognitive impairment, Aβ aggregation, oxidative stress, and neuroinflammation in streptozotocin-induced Alzheimer's disease rat model
    Rajkumar, Manickam
    Kannan, Soundarapandian
    Thangaraj, Ramasundaram
    INFLAMMOPHARMACOLOGY, 2023, 31 (05) : 2751 - 2771